Building “genetic circuits” in cells could kill tumors by depriving them of oxygen

Imagine having cells in your body that can actively repel cancer in a way that makes it theoretically impossible for you to suffer from it.

Researchers at the U.K.โ€™s University of Southampton…have engineered cells with a so-called โ€œbuilt-in genetic circuitโ€ capable of producing a molecule for inhibiting the ability of tumors to grow and survive in the body.

โ€œThere are various defense mechanisms built into human cells, such as proteins that spot DNA damage, but there are also gaps in this defense system that are exploited by disease,โ€ Professor Ali Tavassoli, one of the lead authors of the paper…โ€œWe were wondering if it is possible to equip human cells with the ability to sense and respond to a disease marker….”

In particular, they were interested in a protein called hypoxia-inducible factor 1 (HIF-1), which helps tumors keep growing in low-oxygen environments.

At present, the research is still in the early stages, and nowhere close to ready for human testing. However, it still represents an exciting development which in time could allow scientists to study the effect of inhibiting HIF-1 at keyย stages of tumor development.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: A ‘Built-In Genetic Circuit’ Could Fight Cancer By Starving Tumors of Oxygen

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.โ€™s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Foodโ€”health harming industries or life-saving innovators?
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine โ€œheroโ€ vs. an anti-vax โ€œvillainโ€: โ€˜Bad Vaxxโ€™ video stirs MAHA backlash
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Screenshot 2026-05-11 at 11.30
Despite politicized disinformation, Midwest AI data centers are fueling a solar energy boom
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpointโ€” 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.